Pentavalent Vaccine (DPT-HepB-Hib)

A five-in-one combination vaccine covering diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b (Hib). Introduced in India's UIP to reduce the number of injections.

The Pentavalent Vaccine (DPT-HepB-Hib) is recommended for 6 weeks, 10 weeks, 14 weeks. It falls under the Childhood vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Pentavalent Vaccine (DPT-HepB-Hib) has an efficacy of 90–98%. This means it provides significant protection against Diphtheria and Pertussis. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Fever; local redness; swelling; irritability. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Pentavalent Vaccine (DPT-HepB-Hib) should be avoided by: Prior severe allergic reaction to any component; progressive neurological disorder. Always inform your healthcare provider of your full medical history before vaccination.

The Pentavalent Vaccine (DPT-HepB-Hib) typically costs ₹150 – ₹600 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.